MUMBAI, India, April 11 -- Intellectual Property India has published a patent application (202341067661 A) filed by Msn Laboratories Private Limited, R&D Center, Hyderabad, Telangana, on Oct. 9, 2023, for 'pharmaceutical composition of cabozantinib.'
Inventor(s) include Ravi Kumar Nithiyanandam; and Bala Krishnaiah Medum.
The application for the patent was published on April 11, under issue no. 15/2025.
According to the abstract released by the Intellectual Property India: "The present invention pertains to novel / inventive stable pharmaceutical compositions comprising cabozantinib or pharmaceutically acceptable salts thereof, and at least one pharmaceutically acceptable excipient. Preferably, the pharmaceutically acceptable salts of ca...